Kenichi Tahara
Overview
Explore the profile of Kenichi Tahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isoda A, Tahara K, Ide M
Cureus
. 2024 Jan;
15(12):e51010.
PMID: 38264372
Kikuchi-Fujimoto disease (KFD) is a rare and self-limiting disorder that predominantly affects young individuals of Asian descent. This case report describes familial KFD in partially human leukocyte antigen (HLA)-matched siblings....
2.
Hagihara S, Ohta H, Tanaka J, Shiokawa T, Kida Y, Iguchi Y, et al.
Asian Spine J
. 2023 Oct;
17(5):818-825.
PMID: 37788972
Study Design: This study adopted a retrospective cohort study design. Purpose: This study aimed to clarify the influence of diffuse idiopathic skeletal hyperostosis (DISH) on bone fusion after transforaminal lumbar...
3.
Shibata T, Ota H, Takemitsu Y, Iguchi Y, Kida Y, Tahara K
J Orthop Sci
. 2023 Apr;
PMID: 37105788
Background: Several reports exist on syndromic cervical kyphosis in the elderly, including dropped head syndrome, degenerative spondylosis, and neurological diseases; however, it is rarely reported in young patients especially with...
4.
Toyama K, Nakayama K, Terasaki S, Matsumura I, Kanaya S, Iino H, et al.
J Clin Exp Hematop
. 2023 Mar;
63(1):19-24.
PMID: 36990773
CD5-positive diffuse large B cell lymphoma (CD5+ DLBCL) is a high-risk lymphoma type. Recently, the PEARL5 (a Phase II trial of DA-EPOCH and Rituximab with HD-MTX therapy for newly diagnosed...
5.
Hagihara S, Ohta H, Tanaka J, Shiokawa T, Matsumoto Y, Kida Y, et al.
J Orthop Sci
. 2021 Nov;
28(6):1561-1565.
PMID: 34801339
No abstract available.
6.
Shigematsu K, Komori N, Tahara K, Yamagishi H
Acta Neurol Scand
. 2021 Oct;
145(1):119-122.
PMID: 34716582
Background: Mesenchymal stem cells are expected to have a therapeutic effect on progressive neurodegenerative diseases for which there is currently no fundamental treatment. Aims Of The Study: The aim is...
7.
Shigematsu K, Takeda T, Komori N, Tahara K, Yamagishi H
Med Hypotheses
. 2021 Apr;
150:110572.
PMID: 33799163
We propose the intravenous administration of autologous adipose-derived stem cells as a new treatment for Alzheimer's disease. We hypothesize that the stem cells will secrete neprilysin in the brain to...
8.
Isoda A, Miyazawa Y, Tahara K, Mihara M, Saito A, Matsumoto M, et al.
Intern Med
. 2020 May;
59(16):2041-2045.
PMID: 32389947
We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed acute anemia with a positive direct anti-globulin...
9.
Matsumura I, Mitsui T, Tahara K, Shimizu H, Yanagisawa K, Ishizaki T, et al.
Intern Med
. 2020 Jan;
59(9):1203-1209.
PMID: 31956206
A 69-year-old man with palpitations and decreased blood pressure was referred. Echocardiography showed a mass in the right atrium and cardiac septum. The serum IgG4 level was 1,450 mg/dL. A...
10.
Tahara K, Koiso H, Osaki Y, Sekigami T, Yokohama A, Saitoh T, et al.
Acta Haematol
. 2019 Feb;
141(3):135-137.
PMID: 30783036
No abstract available.